武汉地区32家医院2010~2012年心脑血管类中药注射剂应用调查
|
摘要
目的:评价年武汉市32家医院治疗心脑血管疾病中药注射剂应用情况和趋势。方法:对2010~2012年武汉市32家医院心脑血管类中药注射剂的用药总金额和用药频度进行统计分析。结果:心脑血管类中药注射剂的用药品种多样,用药总金额和用药频度同步稳定增长;三七类和丹参类注射剂在武汉地区的占主导地位;血栓通(规格:100 ng,属三七类)、丹参川芎嗪注射液(规格:5 ml,属丹参类)两个品种应用增长迅速,最具竞争优势。结论:武汉地区心脑血管类中药注射剂应用呈增长趋势。应高度重视药品的不良反应,制药企业须努力提高药品的质量及稳定性,临床应不断提高合理用药水平,最大限度减少不良反应的发生,心脑血管类中药注射剂在该地区的应用仍有发展的空间。
Objective;To evaluate the application of traditional Chinese medicine injection of cardiovascular Drugs in 32 hospitals in Wuhan.Methods;The consumption sum and frequencies of the use of traditional Chinese medicine injection of cardiovascular drugs in 32 hospitals of Wuhan area during the period of 2010-2012 were statistically analyzed.Results;Many varieties of cardiovascular injections,consumption sum and frequencies increased year by year.Sanqi and danshen injections were predominantly used in the area,and Xueshuantong Injection(specifications;lOOmg,belonging to sanqi),and dangshen of Chuarcriongqin Injection(specifications;5ml,belong to danshen) were most competitive.Conclusion:The application of cardiovascular injections in Wuhan area became more and more general.Attention should be paid to adverse drug reactions(ADR).Pharmaceutical enterprises should strive to improve the quality and stability of drugs,and clinical medical workers should constantly improve the level of rational drug use to reduce the incidence of ADR to the greatest degree;thus the development space of cardiovascular injections would be enormous in Wuhan area.
Objective;To evaluate the application of traditional Chinese medicine injection of cardiovascular Drugs in 32 hospitals in Wuhan.Methods;The consumption sum and frequencies of the use of traditional Chinese medicine injection of cardiovascular drugs in 32 hospitals of Wuhan area during the period of 2010-2012 were statistically analyzed.Results;Many varieties of cardiovascular injections,consumption sum and frequencies increased year by year.Sanqi and danshen injections were predominantly used in the area,and Xueshuantong Injection(specifications;lOOmg,belonging to sanqi),and dangshen of Chuarcriongqin Injection(specifications;5ml,belong to danshen) were most competitive.Conclusion:The application of cardiovascular injections in Wuhan area became more and more general.Attention should be paid to adverse drug reactions(ADR).Pharmaceutical enterprises should strive to improve the quality and stability of drugs,and clinical medical workers should constantly improve the level of rational drug use to reduce the incidence of ADR to the greatest degree;thus the development space of cardiovascular injections would be enormous in Wuhan area.
引文
1李贻奎,张金艳.中药注射剂的改进和提高[J].中国中医中药杂志,2011,36(14):1905-1909
2谭菲,刘东.武汉市32家医院2009~2011年银杏叶制剂应用分析[J].药物流行病学杂志,2012,21(11):566-568
3李孝栋,侯超.2010年版《中国药典》一部中活血化瘀类中药制剂分析[J].中国实验方剂学杂志,2012,18(3):246-249
4陈正.探析活血化瘀类药研究进展与应用[J].医学信息(下旬刊),2011,24(7):226-226
5吕冬莲,龙萍.我院2008~2011年中药注射剂药物利用及不良反应分析[J].药物流行病学杂志,2013,22(4):189-193
6陈平,杨莉,徐永祥,等.东莞市2010~2011年430例中药注射剂不良反应分析[J].中国药房,2012,23(19):1806-1808
7国家药品不良反应监测中心.药品不良反应信息通报[J].中国药物警戒,2009,6(1):55-56
8毕凤兰,张力.中药注射剂安全性问题探讨[J].中国药物警戒,2012,9(2):89-92
9周天鸣,王锦玉,仝燕,等.中药注射剂安全性再评价[J].武警医学,2012,23(6):529-530
10李杨华,廖秋霞.43份中药注射剂说明书的调查分析[J].药物流行病学杂志,2012,21(3):130-132
11王世伟,张小慧.中药注射剂的不良反应现状及注意事项[J].中国医药导报,2011,8(4):118-119
2谭菲,刘东.武汉市32家医院2009~2011年银杏叶制剂应用分析[J].药物流行病学杂志,2012,21(11):566-568
3李孝栋,侯超.2010年版《中国药典》一部中活血化瘀类中药制剂分析[J].中国实验方剂学杂志,2012,18(3):246-249
4陈正.探析活血化瘀类药研究进展与应用[J].医学信息(下旬刊),2011,24(7):226-226
5吕冬莲,龙萍.我院2008~2011年中药注射剂药物利用及不良反应分析[J].药物流行病学杂志,2013,22(4):189-193
6陈平,杨莉,徐永祥,等.东莞市2010~2011年430例中药注射剂不良反应分析[J].中国药房,2012,23(19):1806-1808
7国家药品不良反应监测中心.药品不良反应信息通报[J].中国药物警戒,2009,6(1):55-56
8毕凤兰,张力.中药注射剂安全性问题探讨[J].中国药物警戒,2012,9(2):89-92
9周天鸣,王锦玉,仝燕,等.中药注射剂安全性再评价[J].武警医学,2012,23(6):529-530
10李杨华,廖秋霞.43份中药注射剂说明书的调查分析[J].药物流行病学杂志,2012,21(3):130-132
11王世伟,张小慧.中药注射剂的不良反应现状及注意事项[J].中国医药导报,2011,8(4):118-119